The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC)

European Journal of Surgical Oncology

Volumn 35, Issue 10, 2009, Pages 1105-1108

  Cheng, X ^a   Jiang, R ^a   Li, Z T ^a   Tang, J ^a   Cai, S M ^a   Zhang, Z Y ^a   Tian, W J ^a   Zang, R Y ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Mucinous epithelial ovarian cancer; Recurrence; Secondary cytoreductive surgery; Survival

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MINIMAL RESIDUAL DISEASE; MUCINOUS EPITHELIAL OVARIAN CANCER; MULTIPLE CYCLE TREATMENT; OVARY CANCER; PRIORITY JOURNAL; SURVIVAL TIME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 69949103644     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.03.010     Document Type: Article

References (16)

1. McGuire V., Jesser C.A., and Whittemore A.S. Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol Oncol 84 (2002) 399-403
2. Hess V., A'Hern R., Nasiri N., et al. Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment. J Clin Oncol 22 (2004) 1040-1044
3. Zang R.Y., Zhang Z.Y., Li Z.T., Cai S.M., Chen J., and Tang M.Q. Prognostic factors of survival for patients with stage III and stage IV epithelial ovarian cancer. Fudan Xue Bao Yi Xue Ke Xue Ban 28 (2001) 47-50
4. Zang R.Y., Li Z.T., Zhang Z.Y., and Cai S.M. Surgery and salvage chemotherapy for Chinese women with recurrent advanced epithelial ovarian carcinoma: a retrospective case-control study. Int J Gynecol Cancer 13 (2003) 419-427
5. Janicke F., Holscher M., Kuhn W., et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 70 (1992) 2129-2136
6. Segna R.A., Dottino P.R., Mandeli J.P., Konsker K., and Cohen C.J. Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol 11 (1993) 434-439
7. Vaccarello I., Rubin S.C., Vlamis V., et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol 57 (1995) 61-65
8. Eisenkop S.M., Friedman R.L., and Wang H. Secondary cytoreduction for recurrent ovarian cancer. A prospective study. Cancer 76 (1995) 1606-1614
9. Zang R.Y., Zhang Z.Y., Li Z.T., et al. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J Surg Oncol 75 (2000) 26-30
10. Scarabelli C., Gallo A., and Carbone A. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 83 (2001) 504-512
11. Munkarah A., Levenback C., Wolf J.K., et al. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol 81 (2001) 237-241
12. Zang R.Y., Li Z.T., Tang J., et al. Secondary cytoreductive surgery for patients with relapsed ovarian carcinoma: who benefits?. Cancer 100 (2004) 1152-1161
13. Pectasides D., Fountzilas G., Aravantinos G., et al. Advanced stage mucinous epithelial ovarian cancer: the Hellenic cooperative oncology group experience. Gynecol Oncol 97 (2005) 436-441
14. Pisano C., Greggi S., Tambaro R., et al. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study. Anticancer Res 25 (2005) 3501-3505
15. Khunamornpong S., Suprasert P., Pojchamarnwiputh S., Na Chiangmai W., Settakorn J., and Siriaunkgul S. Primary and metastatic mucinous adenocarcinomas of the ovary: evaluation of the diagnostic approach using tumor size and laterality. Gynecol Oncol 101 (2006) 152-157
16. Harrison M.L., Jameson C., and Gore M.E. Mucinous ovarian cancer. Int J Gynecol Cancer 18 (2008) 209-214